There are many vaccines in development to fight Ebola, but few have been shown to have longevity—until now.
Rachael Zimlich, RN
Vaccine hesitancy isn’t as much about additives, side effects, or organic parenting as it is about shifting societal trends toward distrust of medicine and a focus on one’s individual health, according to a new report.
Immune cells that previously were only known to play a role in harmful autoimmune processes may actually be useful in fighting hard-to-detect infections, according to a report.
Immunity wanes within a decade in 10 percent of patients vaccinated against pertussis.
A move to allow pharmacists to administer more vaccines could have a profound effect on adult vaccination rates and vaccine-preventable disease prevalence.
New vaccines that use antibodies to prevent opioids from causing a “high” could help stem abuse and fatal overdoses if human trials are successful.
Tracking, reporting, and organizing immunization-related data is difficult but can improve patient care. HIMSS has recognized several products through its voluntary testing program that can do that job and work with electronic health record systems.
A therapy that uses the immune system to fight cancer has been 97% effective in mice and is moving to human trials.
Long-thought to be primarily caused by smoking and other exposures, scientists now believe that congenital changes to lung tissues with a genetic link may also be to blame.
Less than 10% of eligible COPD patients were referred to pulmonary rehabilitation programs, according to a new UK study.